The Fraud ArchiveThe Fraud Archive
Back to Home
Corporate Accounting Fraud

Abraaj Group: The Emerging Markets Fund Built on Misappropriated Capital

Abraaj sold itself as the engine of modern capital for the developing world. Behind the pitch was a quieter machinery: investor money siphoned to keep the firm alive, until the gaps in the story became too large to hide.

2002 - 2018Americas2002–2018

Quick Facts

Period
2002 - 2018
Region
Americas
Key Figures
Arif Naqvi, Bill & Melinda Gates Foundation, FBI and SEC investigators +2 more

Key Figures

The Story

This narrative combines documented history with dramatized scenes for storytelling purposes.

Timeline

Abraaj's Founding in Dubai

**2002-01** — Abraaj Group begins operating in Dubai, positioning itself as a private equity platform for emerging markets. The city’s permissive, global-facing financial environment becomes the setting for the firm’s rapid rise.

Healthcare Investing Becomes a Flagship Theme

**2005-01** — Abraaj expands into healthcare investing and begins marketing the strategy as both financially attractive and socially beneficial. The fund structure later becomes central to allegations that restricted capital was misused.

Global Fundraising Accelerates

**2010-01** — Abraaj deepens relationships with institutional investors, foundations, and development actors. Social-impact branding and emerging-market access help the firm recruit capital across multiple jurisdictions.

Operational Pressure and Capital Commingling

**2014-01** — According to later allegations, the firm increasingly relied on investor funds to support corporate needs and liquidity pressures. The public record suggests the paper trail grew more complex as the organization expanded.

Investors and Journalists Begin Asking Harder Questions

**2018-01** — Concerns over the healthcare fund’s use of capital move into public view. Investigative reporting and investor inquiries force Abraaj to address allegations that money was diverted from its stated purpose.

Forensic Review and Insolvency Pressure

**2018-06** — As scrutiny intensifies, forensic reviews and restructuring efforts examine the firm’s fund flows. The crisis sharpens around the healthcare vehicles and the question of where investor capital actually went.

U.S. Securities Complaint Filed

**2018-10-01** — The SEC files civil actions alleging misrepresentations and misuse of fund capital connected to Abraaj. The filing turns the scandal into an enforceable legal case and widens international attention.

Charges Announced Against Arif Naqvi

**2019-02-12** — U.S. prosecutors announce criminal charges tied to the fraud scheme. The case now includes allegations of investor deception and the misuse of healthcare fund capital for firm operations.

Arif Naqvi Arrested in London

**2019-02-12** — Naqvi is arrested in London after U.S. authorities move to secure the case. His arrest marks the point at which the collapse becomes a criminal proceeding rather than a private dispute.

Trial Proceedings Advance in U.S. Court

**2021-09-06** — As litigation moves forward in federal court, the factual record around investor misuse, fund transfers, and misrepresentations becomes central. The courtroom phase begins to define the public understanding of the scheme.

Arif Naqvi Sentenced

**2022-05-11** — Naqvi receives a 100-year federal sentence in the United States. The punishment closes one major chapter of the case, though asset recovery and civil disputes continue.

Restitution and Recovery Efforts Continue

**2024-01** — Recovery efforts, settlements, and related proceedings continue to address the losses from the Abraaj collapse. The broader recovery remains incomplete, and the case persists as a cautionary tale in private markets.

Sources

Explore Related Archives

Financial fraud has toppled companies, entangled governments, and exploited trust across borders. Explore the broader context through our sister archives.